Shots:
- The US FDA has granted clearance to Flu and COVID-19 Test, an at-home PCR test capable of detecting multiple respiratory viruses, expanding its portfolio of over-the-counter molecular diagnostics
- The test delivers PCR-quality results in 30min. & detects COVID-19 and influenza A/B at home, enabling earlier diagnosis & timely treatment decisions, incl. access to antiviral therapies when they are most effective
- The newly cleared test builds on Visby’s existing at-home PCR platform and will be eligible for FSA & HSA reimbursement, while the company continues to expand nationwide access to its home diagnostics
Ref: Businesswire | Image: Visby Medical | Press Release
Related News: Median Technologies Receives CE Mark for eyonis LCS to Detect and Diagnose Lung Cancer
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
